APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IL-12 Receptor Antagonist

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global IL-12 Receptor Antagonist Market Analysis and Forecast 2026-2032

Report ID 174001580227 December 2025198 pages

Choose your research edition.

Industry ResearchIL-12 Receptor Antagonist Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-12 Receptor Antagonist Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal IL-12 Receptor Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-12 Receptor Antagonist Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-12 Receptor Antagonist Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global IL-12 Receptor Antagonist market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for IL-12 Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for IL-12 Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for IL-12 Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for IL-12 Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of IL-12 Receptor Antagonist include Amgen, Biocon Biologics, Celltrion, Janssen Pharmaceuticals, Samsung Bioepis, Sandoz, Teva, Bio-Thera Solutions and Huadong Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for IL-12 Receptor Antagonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of IL-12 Receptor Antagonist, also provides the sales of main regions and countries. Of the upcoming market potential for IL-12 Receptor Antagonist, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IL-12 Receptor Antagonist sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IL-12 Receptor Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for IL-12 Receptor Antagonist sales, projected growth trends, production technology, application and end-user industry.

IL-12 Receptor Antagonist Segment by Company

Amgen

Biocon Biologics

Celltrion

Janssen Pharmaceuticals

Samsung Bioepis

Sandoz

Teva

Bio-Thera Solutions

Huadong Medicine

Qyuns Therapeutics

IL-12 Receptor Antagonist Segment by Type

Ustekinumab

Briakinumab

Other

IL-12 Receptor Antagonist Segment by Application

Plaque Psoriasis

Crohn's Disease

Ulcerative Colitis

Rheumatoid Arthritis

Other

IL-12 Receptor Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-12 Receptor Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-12 Receptor Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-12 Receptor Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of IL-12 Receptor Antagonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of IL-12 Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IL-12 Receptor Antagonist sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global IL-12 Receptor Antagonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ustekinumab Major Manufacturers Table 3. Briakinumab Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global IL-12 Receptor Antagonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Plaque Psoriasis Major Manufacturers Table 7. Crohn's Disease Major Manufacturers Table 8. Ulcerative Colitis Major Manufacturers Table 9. Rheumatoid Arthritis Major Manufacturers Table 10. Other Major Manufacturers Table 11. IL-12 Receptor Antagonist Industry Trends Table 12. IL-12 Receptor Antagonist Industry Drivers Table 13. IL-12 Receptor Antagonist Industry Opportunities and Challenges Table 14. IL-12 Receptor Antagonist Industry Restraints Table 15. Global IL-12 Receptor Antagonist Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global IL-12 Receptor Antagonist Revenue by Region (2021-2026) & (US$ Million) Table 17. Global IL-12 Receptor Antagonist Revenue by Region (2027-2032) & (US$ Million) Table 18. Global IL-12 Receptor Antagonist Revenue Market Share by Region (2021-2026) Table 19. Global IL-12 Receptor Antagonist Revenue Market Share by Region (2027-2032) Table 20. Global IL-12 Receptor Antagonist Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global IL-12 Receptor Antagonist Sales by Region (2021-2026) & (K Units) Table 22. Global IL-12 Receptor Antagonist Sales by Region (2027-2032) & (K Units) Table 23. Global IL-12 Receptor Antagonist Sales Market Share by Region (2021-2026) Table 24. Global IL-12 Receptor Antagonist Sales Market Share by Region (2027-2032) Table 25. Global IL-12 Receptor Antagonist Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global IL-12 Receptor Antagonist Revenue Market Share by Manufacturers (2021-2026) Table 27. Global IL-12 Receptor Antagonist Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global IL-12 Receptor Antagonist Sales Market Share by Manufacturers (2021-2026) Table 29. Global IL-12 Receptor Antagonist Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global IL-12 Receptor Antagonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global IL-12 Receptor Antagonist Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global IL-12 Receptor Antagonist Manufacturers, Product Type & Application Table 33. Global IL-12 Receptor Antagonist Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global IL-12 Receptor Antagonist by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global IL-12 Receptor Antagonist Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global IL-12 Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 38. Global IL-12 Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 39. Global IL-12 Receptor Antagonist Revenue Market Share by Type (2021-2026) Table 40. Global IL-12 Receptor Antagonist Revenue Market Share by Type (2027-2032) Table 41. Global IL-12 Receptor Antagonist Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 43. Global IL-12 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 44. Global IL-12 Receptor Antagonist Sales Market Share by Type (2021-2026) Table 45. Global IL-12 Receptor Antagonist Sales Market Share by Type (2027-2032) Table 46. Global IL-12 Receptor Antagonist Price by Type (2021-2026) & (US$/Unit) Table 47. Global IL-12 Receptor Antagonist Price by Type (2027-2032) & (US$/Unit) Table 48. Global IL-12 Receptor Antagonist Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global IL-12 Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 50. Global IL-12 Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 51. Global IL-12 Receptor Antagonist Revenue Market Share by Application (2021-2026) Table 52. Global IL-12 Receptor Antagonist Revenue Market Share by Application (2027-2032) Table 53. Global IL-12 Receptor Antagonist Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 55. Global IL-12 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 56. Global IL-12 Receptor Antagonist Sales Market Share by Application (2021-2026) Table 57. Global IL-12 Receptor Antagonist Sales Market Share by Application (2027-2032) Table 58. Global IL-12 Receptor Antagonist Price by Application (2021-2026) & (US$/Unit) Table 59. Global IL-12 Receptor Antagonist Price by Application (2027-2032) & (US$/Unit) Table 60. Amgen Company Information Table 61. Amgen Business Overview Table 62. Amgen IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Amgen IL-12 Receptor Antagonist Product Portfolio Table 64. Amgen Recent Development Table 65. Biocon Biologics Company Information Table 66. Biocon Biologics Business Overview Table 67. Biocon Biologics IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Biocon Biologics IL-12 Receptor Antagonist Product Portfolio Table 69. Biocon Biologics Recent Development Table 70. Celltrion Company Information Table 71. Celltrion Business Overview Table 72. Celltrion IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Celltrion IL-12 Receptor Antagonist Product Portfolio Table 74. Celltrion Recent Development Table 75. Janssen Pharmaceuticals Company Information Table 76. Janssen Pharmaceuticals Business Overview Table 77. Janssen Pharmaceuticals IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Janssen Pharmaceuticals IL-12 Receptor Antagonist Product Portfolio Table 79. Janssen Pharmaceuticals Recent Development Table 80. Samsung Bioepis Company Information Table 81. Samsung Bioepis Business Overview Table 82. Samsung Bioepis IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Samsung Bioepis IL-12 Receptor Antagonist Product Portfolio Table 84. Samsung Bioepis Recent Development Table 85. Sandoz Company Information Table 86. Sandoz Business Overview Table 87. Sandoz IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Sandoz IL-12 Receptor Antagonist Product Portfolio Table 89. Sandoz Recent Development Table 90. Teva Company Information Table 91. Teva Business Overview Table 92. Teva IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Teva IL-12 Receptor Antagonist Product Portfolio Table 94. Teva Recent Development Table 95. Bio-Thera Solutions Company Information Table 96. Bio-Thera Solutions Business Overview Table 97. Bio-Thera Solutions IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Bio-Thera Solutions IL-12 Receptor Antagonist Product Portfolio Table 99. Bio-Thera Solutions Recent Development Table 100. Huadong Medicine Company Information Table 101. Huadong Medicine Business Overview Table 102. Huadong Medicine IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Huadong Medicine IL-12 Receptor Antagonist Product Portfolio Table 104. Huadong Medicine Recent Development Table 105. Qyuns Therapeutics Company Information Table 106. Qyuns Therapeutics Business Overview Table 107. Qyuns Therapeutics IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Qyuns Therapeutics IL-12 Receptor Antagonist Product Portfolio Table 109. Qyuns Therapeutics Recent Development Table 110. North America IL-12 Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 111. North America IL-12 Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 112. North America IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 113. North America IL-12 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 114. North America IL-12 Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 115. North America IL-12 Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 116. North America IL-12 Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 117. North America IL-12 Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 118. North America IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 119. North America IL-12 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 120. North America IL-12 Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 121. North America IL-12 Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 122. North America IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. North America IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. North America IL-12 Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. North America IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 126. North America IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 127. North America IL-12 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 128. North America IL-12 Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 129. North America IL-12 Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 130. United States IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 131. Canada IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 132. Mexico IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 133. Europe IL-12 Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe IL-12 Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 136. Europe IL-12 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 137. Europe IL-12 Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Europe IL-12 Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Europe IL-12 Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe IL-12 Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 142. Europe IL-12 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 143. Europe IL-12 Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Europe IL-12 Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Europe IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Europe IL-12 Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Europe IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Europe IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 150. Europe IL-12 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 151. Europe IL-12 Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Europe IL-12 Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Germany IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 154. France IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 155. U.K. IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 156. Italy IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 157. Russia IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 158. Spain IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 159. Netherlands IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 160. Switzerland IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 161. Sweden IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 162. Poland IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 163. China IL-12 Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 164. China IL-12 Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 165. China IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 166. China IL-12 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 167. China IL-12 Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 168. China IL-12 Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 169. China IL-12 Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 170. China IL-12 Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 171. China IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 172. China IL-12 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 173. China IL-12 Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 174. China IL-12 Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia IL-12 Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 176. Asia IL-12 Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 177. Asia IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 178. Asia IL-12 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 179. Asia IL-12 Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 180. Asia IL-12 Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 181. Asia IL-12 Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 182. Asia IL-12 Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 183. Asia IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 184. Asia IL-12 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 185. Asia IL-12 Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 186. Asia IL-12 Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Asia IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Asia IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Asia IL-12 Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Asia IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. Asia IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 192. Asia IL-12 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 193. Asia IL-12 Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 194. Asia IL-12 Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Japan IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 196. South Korea IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 197. India IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 198. Australia IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 199. Taiwan IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 200. Southeast Asia IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 201. SAMEA IL-12 Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 202. SAMEA IL-12 Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 203. SAMEA IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 204. SAMEA IL-12 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 205. SAMEA IL-12 Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 206. SAMEA IL-12 Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 207. SAMEA IL-12 Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 208. SAMEA IL-12 Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 209. SAMEA IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 210. SAMEA IL-12 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 211. SAMEA IL-12 Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 212. SAMEA IL-12 Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 213. SAMEA IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. SAMEA IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. SAMEA IL-12 Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. SAMEA IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 217. SAMEA IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 218. SAMEA IL-12 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 219. SAMEA IL-12 Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 220. SAMEA IL-12 Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 221. Brazil IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 222. Argentina IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 223. Chile IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 224. Colombia IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 225. Peru IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 226. Saudi Arabia IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 227. Israel IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 228. UAE IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 229. Turkey IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 230. Iran IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 231. Egypt IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 232. Key Raw Materials Table 233. Raw Materials Key Suppliers Table 234. IL-12 Receptor Antagonist Distributors List Table 235. IL-12 Receptor Antagonist Customers List Table 236. Research Programs/Design for This Report Table 237. Authors List of This Report Table 238. Secondary Sources Table 239. Primary Sources List of Figures Figure 1. IL-12 Receptor Antagonist Image Figure 2. Global IL-12 Receptor Antagonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-12 Receptor Antagonist Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ustekinumab Image Figure 5. Briakinumab Image Figure 6. Other Image Figure 7. Global IL-12 Receptor Antagonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global IL-12 Receptor Antagonist Market Size Share 2021 VS 2025 VS 2032 Figure 9. Plaque Psoriasis Image Figure 10. Crohn's Disease Image Figure 11. Ulcerative Colitis Image Figure 12. Rheumatoid Arthritis Image Figure 13. Other Image Figure 14. Global IL-12 Receptor Antagonist Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global IL-12 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Figure 16. Global IL-12 Receptor Antagonist Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global IL-12 Receptor Antagonist Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global IL-12 Receptor Antagonist Revenue Market Share by Region (2021-2032) Figure 19. Global IL-12 Receptor Antagonist Sales (2021-2032) & (K Units) Figure 20. Global IL-12 Receptor Antagonist Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global IL-12 Receptor Antagonist Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico IL-12 Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 23. Europe IL-12 Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 24. China IL-12 Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) IL-12 Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa IL-12 Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 27. Global IL-12 Receptor Antagonist Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global IL-12 Receptor Antagonist Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global IL-12 Receptor Antagonist Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global IL-12 Receptor Antagonist Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global IL-12 Receptor Antagonist Revenue Market Share by Type (2021-2032) Figure 33. Global IL-12 Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global IL-12 Receptor Antagonist Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global IL-12 Receptor Antagonist Sales Market Share by Type (2021-2032) Figure 36. Global IL-12 Receptor Antagonist Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global IL-12 Receptor Antagonist Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global IL-12 Receptor Antagonist Revenue Market Share by Application (2021-2032) Figure 39. Global IL-12 Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global IL-12 Receptor Antagonist Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global IL-12 Receptor Antagonist Sales Market Share by Application (2021-2032) Figure 42. North America IL-12 Receptor Antagonist Revenue Share by Type (2021-2032) Figure 43. North America IL-12 Receptor Antagonist Sales Share by Type (2021-2032) Figure 44. North America IL-12 Receptor Antagonist Revenue Share by Application (2021-2032) Figure 45. North America IL-12 Receptor Antagonist Sales Share by Application (2021-2032) Figure 46. North America IL-12 Receptor Antagonist Revenue Share by Country (2021-2032) Figure 47. North America IL-12 Receptor Antagonist Sales Share by Country (2021-2032) Figure 48. Europe IL-12 Receptor Antagonist Revenue Share by Type (2021-2032) Figure 49. Europe IL-12 Receptor Antagonist Sales Share by Type (2021-2032) Figure 50. Europe IL-12 Receptor Antagonist Revenue Share by Application (2021-2032) Figure 51. Europe IL-12 Receptor Antagonist Sales Share by Application (2021-2032) Figure 52. Europe IL-12 Receptor Antagonist Revenue Share by Country (2021-2032) Figure 53. Europe IL-12 Receptor Antagonist Sales Share by Country (2021-2032) Figure 54. China IL-12 Receptor Antagonist Revenue Share by Type (2021-2032) Figure 55. China IL-12 Receptor Antagonist Sales Share by Type (2021-2032) Figure 56. China IL-12 Receptor Antagonist Revenue Share by Application (2021-2032) Figure 57. China IL-12 Receptor Antagonist Sales Share by Application (2021-2032) Figure 58. Asia IL-12 Receptor Antagonist Revenue Share by Type (2021-2032) Figure 59. Asia IL-12 Receptor Antagonist Sales Share by Type (2021-2032) Figure 60. Asia IL-12 Receptor Antagonist Revenue Share by Application (2021-2032) Figure 61. Asia IL-12 Receptor Antagonist Sales Share by Application (2021-2032) Figure 62. Asia IL-12 Receptor Antagonist Revenue Share by Country (2021-2032) Figure 63. Asia IL-12 Receptor Antagonist Sales Share by Country (2021-2032) Figure 64. SAMEA IL-12 Receptor Antagonist Revenue Share by Type (2021-2032) Figure 65. SAMEA IL-12 Receptor Antagonist Sales Share by Type (2021-2032) Figure 66. SAMEA IL-12 Receptor Antagonist Revenue Share by Application (2021-2032) Figure 67. SAMEA IL-12 Receptor Antagonist Sales Share by Application (2021-2032) Figure 68. SAMEA IL-12 Receptor Antagonist Revenue Share by Country (2021-2032) Figure 69. SAMEA IL-12 Receptor Antagonist Sales Share by Country (2021-2032) Figure 70. IL-12 Receptor Antagonist Value Chain Figure 71. Manufacturing Cost Structure Figure 72. IL-12 Receptor Antagonist Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Ustekinumab
  • Briakinumab
  • Other
Applications
  • Plaque Psoriasis
  • Crohn's Disease
  • Ulcerative Colitis
  • Rheumatoid Arthritis
  • Other
Companies covered
  • Amgen
  • Biocon Biologics
  • Celltrion
  • Janssen Pharmaceuticals
  • Samsung Bioepis
  • Sandoz
  • Teva
  • Bio-Thera Solutions
  • Huadong Medicine
  • Qyuns Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 IL-12 Receptor Antagonist Market by Type
  3. 1.2.1 Global IL-12 Receptor Antagonist Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ustekinumab
  5. 1.2.3 Briakinumab
  6. 1.2.4 Other
  7. 1.3 IL-12 Receptor Antagonist Market by Application
  8. 1.3.1 Global IL-12 Receptor Antagonist Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Plaque Psoriasis
  10. 1.3.3 Crohn's Disease
  11. 1.3.4 Ulcerative Colitis
  12. 1.3.5 Rheumatoid Arthritis
  13. 1.3.6 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 IL-12 Receptor Antagonist Market Dynamics
  1. 2.1 IL-12 Receptor Antagonist Industry Trends
  2. 2.2 IL-12 Receptor Antagonist Industry Drivers
  3. 2.3 IL-12 Receptor Antagonist Industry Opportunities and Challenges
  4. 2.4 IL-12 Receptor Antagonist Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global IL-12 Receptor Antagonist Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global IL-12 Receptor Antagonist Revenue by Region
  3. 3.2.1 Global IL-12 Receptor Antagonist Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global IL-12 Receptor Antagonist Revenue by Region (2021-2026)
  5. 3.2.3 Global IL-12 Receptor Antagonist Revenue by Region (2027-2032)
  6. 3.2.4 Global IL-12 Receptor Antagonist Revenue Market Share by Region (2021-2032)
  7. 3.3 Global IL-12 Receptor Antagonist Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global IL-12 Receptor Antagonist Sales by Region
  9. 3.4.1 Global IL-12 Receptor Antagonist Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global IL-12 Receptor Antagonist Sales by Region (2021-2026)
  11. 3.4.3 Global IL-12 Receptor Antagonist Sales by Region (2027-2032)
  12. 3.4.4 Global IL-12 Receptor Antagonist Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global IL-12 Receptor Antagonist Revenue by Manufacturers
  2. 4.1.1 Global IL-12 Receptor Antagonist Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global IL-12 Receptor Antagonist Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global IL-12 Receptor Antagonist Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global IL-12 Receptor Antagonist Sales by Manufacturers
  6. 4.2.1 Global IL-12 Receptor Antagonist Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global IL-12 Receptor Antagonist Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global IL-12 Receptor Antagonist Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global IL-12 Receptor Antagonist Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global IL-12 Receptor Antagonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global IL-12 Receptor Antagonist Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global IL-12 Receptor Antagonist Manufacturers, Product Type & Application
  13. 4.7 Global IL-12 Receptor Antagonist Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global IL-12 Receptor Antagonist Market CR5 and HHI
  16. 4.8.2 2025 IL-12 Receptor Antagonist Tier 1, Tier 2, and Tier 3
5 IL-12 Receptor Antagonist Market by Type
  1. 5.1 Global IL-12 Receptor Antagonist Revenue by Type
  2. 5.1.1 Global IL-12 Receptor Antagonist Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global IL-12 Receptor Antagonist Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global IL-12 Receptor Antagonist Revenue Market Share by Type (2021-2032)
  5. 5.2 Global IL-12 Receptor Antagonist Sales by Type
  6. 5.2.1 Global IL-12 Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IL-12 Receptor Antagonist Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global IL-12 Receptor Antagonist Sales Market Share by Type (2021-2032)
  9. 5.3 Global IL-12 Receptor Antagonist Price by Type
6 IL-12 Receptor Antagonist Market by Application
  1. 6.1 Global IL-12 Receptor Antagonist Revenue by Application
  2. 6.1.1 Global IL-12 Receptor Antagonist Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global IL-12 Receptor Antagonist Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global IL-12 Receptor Antagonist Revenue Market Share by Application (2021-2032)
  5. 6.2 Global IL-12 Receptor Antagonist Sales by Application
  6. 6.2.1 Global IL-12 Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global IL-12 Receptor Antagonist Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global IL-12 Receptor Antagonist Sales Market Share by Application (2021-2032)
  9. 6.3 Global IL-12 Receptor Antagonist Price by Application
7 Company Profiles
  1. 7.1 Amgen
  2. 7.1.1 Amgen Company Information
  3. 7.1.2 Amgen Business Overview
  4. 7.1.3 Amgen IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amgen IL-12 Receptor Antagonist Product Portfolio
  6. 7.1.5 Amgen Recent Developments
  7. 7.2 Biocon Biologics
  8. 7.2.1 Biocon Biologics Company Information
  9. 7.2.2 Biocon Biologics Business Overview
  10. 7.2.3 Biocon Biologics IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Biocon Biologics IL-12 Receptor Antagonist Product Portfolio
  12. 7.2.5 Biocon Biologics Recent Developments
  13. 7.3 Celltrion
  14. 7.3.1 Celltrion Company Information
  15. 7.3.2 Celltrion Business Overview
  16. 7.3.3 Celltrion IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Celltrion IL-12 Receptor Antagonist Product Portfolio
  18. 7.3.5 Celltrion Recent Developments
  19. 7.4 Janssen Pharmaceuticals
  20. 7.4.1 Janssen Pharmaceuticals Company Information
  21. 7.4.2 Janssen Pharmaceuticals Business Overview
  22. 7.4.3 Janssen Pharmaceuticals IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Janssen Pharmaceuticals IL-12 Receptor Antagonist Product Portfolio
  24. 7.4.5 Janssen Pharmaceuticals Recent Developments
  25. 7.5 Samsung Bioepis
  26. 7.5.1 Samsung Bioepis Company Information
  27. 7.5.2 Samsung Bioepis Business Overview
  28. 7.5.3 Samsung Bioepis IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Samsung Bioepis IL-12 Receptor Antagonist Product Portfolio
  30. 7.5.5 Samsung Bioepis Recent Developments
  31. 7.6 Sandoz
  32. 7.6.1 Sandoz Company Information
  33. 7.6.2 Sandoz Business Overview
  34. 7.6.3 Sandoz IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz IL-12 Receptor Antagonist Product Portfolio
  36. 7.6.5 Sandoz Recent Developments
  37. 7.7 Teva
  38. 7.7.1 Teva Company Information
  39. 7.7.2 Teva Business Overview
  40. 7.7.3 Teva IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Teva IL-12 Receptor Antagonist Product Portfolio
  42. 7.7.5 Teva Recent Developments
  43. 7.8 Bio-Thera Solutions
  44. 7.8.1 Bio-Thera Solutions Company Information
  45. 7.8.2 Bio-Thera Solutions Business Overview
  46. 7.8.3 Bio-Thera Solutions IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bio-Thera Solutions IL-12 Receptor Antagonist Product Portfolio
  48. 7.8.5 Bio-Thera Solutions Recent Developments
  49. 7.9 Huadong Medicine
  50. 7.9.1 Huadong Medicine Company Information
  51. 7.9.2 Huadong Medicine Business Overview
  52. 7.9.3 Huadong Medicine IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Huadong Medicine IL-12 Receptor Antagonist Product Portfolio
  54. 7.9.5 Huadong Medicine Recent Developments
  55. 7.10 Qyuns Therapeutics
  56. 7.10.1 Qyuns Therapeutics Company Information
  57. 7.10.2 Qyuns Therapeutics Business Overview
  58. 7.10.3 Qyuns Therapeutics IL-12 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Qyuns Therapeutics IL-12 Receptor Antagonist Product Portfolio
  60. 7.10.5 Qyuns Therapeutics Recent Developments
8 North America
  1. 8.1 North America IL-12 Receptor Antagonist Market Size by Type
  2. 8.1.1 North America IL-12 Receptor Antagonist Revenue by Type (2021-2032)
  3. 8.1.2 North America IL-12 Receptor Antagonist Sales by Type (2021-2032)
  4. 8.1.3 North America IL-12 Receptor Antagonist Price by Type (2021-2032)
  5. 8.2 North America IL-12 Receptor Antagonist Market Size by Application
  6. 8.2.1 North America IL-12 Receptor Antagonist Revenue by Application (2021-2032)
  7. 8.2.2 North America IL-12 Receptor Antagonist Sales by Application (2021-2032)
  8. 8.2.3 North America IL-12 Receptor Antagonist Price by Application (2021-2032)
  9. 8.3 North America IL-12 Receptor Antagonist Market Size by Country
  10. 8.3.1 North America IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America IL-12 Receptor Antagonist Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe IL-12 Receptor Antagonist Market Size by Type
  2. 9.1.1 Europe IL-12 Receptor Antagonist Revenue by Type (2021-2032)
  3. 9.1.2 Europe IL-12 Receptor Antagonist Sales by Type (2021-2032)
  4. 9.1.3 Europe IL-12 Receptor Antagonist Price by Type (2021-2032)
  5. 9.2 Europe IL-12 Receptor Antagonist Market Size by Application
  6. 9.2.1 Europe IL-12 Receptor Antagonist Revenue by Application (2021-2032)
  7. 9.2.2 Europe IL-12 Receptor Antagonist Sales by Application (2021-2032)
  8. 9.2.3 Europe IL-12 Receptor Antagonist Price by Application (2021-2032)
  9. 9.3 Europe IL-12 Receptor Antagonist Market Size by Country
  10. 9.3.1 Europe IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe IL-12 Receptor Antagonist Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China IL-12 Receptor Antagonist Market Size by Type
  2. 10.1.1 China IL-12 Receptor Antagonist Revenue by Type (2021-2032)
  3. 10.1.2 China IL-12 Receptor Antagonist Sales by Type (2021-2032)
  4. 10.1.3 China IL-12 Receptor Antagonist Price by Type (2021-2032)
  5. 10.2 China IL-12 Receptor Antagonist Market Size by Application
  6. 10.2.1 China IL-12 Receptor Antagonist Revenue by Application (2021-2032)
  7. 10.2.2 China IL-12 Receptor Antagonist Sales by Application (2021-2032)
  8. 10.2.3 China IL-12 Receptor Antagonist Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia IL-12 Receptor Antagonist Market Size by Type
  2. 11.1.1 Asia IL-12 Receptor Antagonist Revenue by Type (2021-2032)
  3. 11.1.2 Asia IL-12 Receptor Antagonist Sales by Type (2021-2032)
  4. 11.1.3 Asia IL-12 Receptor Antagonist Price by Type (2021-2032)
  5. 11.2 Asia IL-12 Receptor Antagonist Market Size by Application
  6. 11.2.1 Asia IL-12 Receptor Antagonist Revenue by Application (2021-2032)
  7. 11.2.2 Asia IL-12 Receptor Antagonist Sales by Application (2021-2032)
  8. 11.2.3 Asia IL-12 Receptor Antagonist Price by Application (2021-2032)
  9. 11.3 Asia IL-12 Receptor Antagonist Market Size by Country
  10. 11.3.1 Asia IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia IL-12 Receptor Antagonist Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA IL-12 Receptor Antagonist Market Size by Type
  2. 12.1.1 SAMEA IL-12 Receptor Antagonist Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA IL-12 Receptor Antagonist Sales by Type (2021-2032)
  4. 12.1.3 SAMEA IL-12 Receptor Antagonist Price by Type (2021-2032)
  5. 12.2 SAMEA IL-12 Receptor Antagonist Market Size by Application
  6. 12.2.1 SAMEA IL-12 Receptor Antagonist Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA IL-12 Receptor Antagonist Sales by Application (2021-2032)
  8. 12.2.3 SAMEA IL-12 Receptor Antagonist Price by Application (2021-2032)
  9. 12.3 SAMEA IL-12 Receptor Antagonist Market Size by Country
  10. 12.3.1 SAMEA IL-12 Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA IL-12 Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA IL-12 Receptor Antagonist Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 IL-12 Receptor Antagonist Value Chain Analysis
  2. 13.1.1 IL-12 Receptor Antagonist Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 IL-12 Receptor Antagonist Production Mode & Process
  6. 13.2 IL-12 Receptor Antagonist Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 IL-12 Receptor Antagonist Distributors
  9. 13.2.3 IL-12 Receptor Antagonist Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst